Junjian Wang

3.9k total citations · 1 hit paper
107 papers, 2.7k citations indexed

About

Junjian Wang is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Junjian Wang has authored 107 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Molecular Biology, 19 papers in Oncology and 19 papers in Cancer Research. Recurrent topics in Junjian Wang's work include Estrogen and related hormone effects (10 papers), Epigenetics and DNA Methylation (10 papers) and Histone Deacetylase Inhibitors Research (8 papers). Junjian Wang is often cited by papers focused on Estrogen and related hormone effects (10 papers), Epigenetics and DNA Methylation (10 papers) and Histone Deacetylase Inhibitors Research (8 papers). Junjian Wang collaborates with scholars based in China, United States and Canada. Junjian Wang's co-authors include Chi‐Wai Wong, Jianzhen Xu, June X. Zou, Zhijian Duan, Hong-Wu Chen, Haibin Wang, Peiqing Liu, Zhiyan Huang, Fang Fang and Jian Jian Li and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Nature Medicine.

In The Last Decade

Junjian Wang

104 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inhibition of STAT3-ferroptosis negative regulatory axis suppresses tumor growth and alleviates chemoresistance in gastric cancer

2022 323 citations Huaxuan Li, Lin Zhong et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Junjian Wang China	28	1.6k	560	494	428	203	107	2.7k
Sweaty Koul United States	23	1.6k 1.0×	551 1.0×	481 1.0×	631 1.5×	256 1.3×	69	2.9k
Larisa Nonn United States	30	1.5k 1.0×	772 1.4×	411 0.8×	385 0.9×	316 1.6×	69	2.9k
Marco A. De Velasco Japan	33	1.8k 1.1×	664 1.2×	978 2.0×	632 1.5×	249 1.2×	115	3.2k
Juan Ángel Fresno Vara Spain	21	2.2k 1.4×	919 1.6×	810 1.6×	411 1.0×	192 0.9×	66	3.3k
Yingli Wu China	32	2.2k 1.4×	541 1.0×	516 1.0×	213 0.5×	145 0.7×	145	3.2k
Mei Wang China	34	2.4k 1.6×	718 1.3×	617 1.2×	331 0.8×	295 1.5×	146	4.0k
Fang Bai China	33	2.0k 1.3×	326 0.6×	405 0.8×	361 0.8×	133 0.7×	173	3.5k
Rosanna Paciucci Spain	25	1.7k 1.1×	707 1.3×	540 1.1×	352 0.8×	104 0.5×	43	2.8k
Hongbiao Huang China	37	2.3k 1.5×	579 1.0×	833 1.7×	340 0.8×	189 0.9×	101	3.5k
Weixiong Zhong United States	41	2.3k 1.5×	752 1.3×	545 1.1×	468 1.1×	230 1.1×	117	4.7k

Countries citing papers authored by Junjian Wang

Since Specialization

Citations

This map shows the geographic impact of Junjian Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junjian Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junjian Wang more than expected).

Fields of papers citing papers by Junjian Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junjian Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junjian Wang. The network helps show where Junjian Wang may publish in the future.

Co-authorship network of co-authors of Junjian Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Junjian Wang. A scholar is included among the top collaborators of Junjian Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junjian Wang. Junjian Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Yuan, Bei Cao, Qianqian Wang, et al.. (2025). Ligand supplementation restores the cancer therapy efficacy of the antirheumatic drug auranofin from serum inactivation. Nature Communications. 16(1). 7347–7347. 3 indexed citations

Cheng, Yabin, Ying Liu, Yahong Yu, et al.. (2025). 1848MO Phase II study of firmonertinib in patients with previously treated advanced/metastatic non-small cell lung cancer (mNSCLC) with EGFR exon 20 insertion (ex20ins) mutations. Annals of Oncology. 36. S994–S994.

Li, Zhen, Songlin Wu, Yunjia Liu, et al.. (2024). Water-stable aggregation and organic matter stabilisation by native plant Acacia auriculiformis in an early Technosol eco-engineered from Fe-ore tailings. SHILAP Revista de lepidopterología. 2(4). 100115–100115. 1 indexed citations

Wang, Xiaojuan, Hong Wang, Shuai Ma, et al.. (2024). Targeting KPNB1 with genkwadaphnin suppresses gastric cancer progression through the Nur77-mediated signaling pathway. European Journal of Pharmacology. 977. 176697–176697. 1 indexed citations

Ma, Shuai, Yiwei Hu, Xiaojuan Wang, et al.. (2023). Marine fungus-derived alkaloid inhibits the growth and metastasis of gastric cancer via targeting mTORC1 signaling pathway. Chemico-Biological Interactions. 382. 110618–110618. 8 indexed citations

Zhang, Cheng, Jiaojiao Yu, Chen Yang, et al.. (2023). Wild-type IDH1 maintains NSCLC stemness and chemoresistance through activation of the serine biosynthetic pathway. Science Translational Medicine. 15(726). eade4113–eade4113. 13 indexed citations

Han, Lu, Taotao Zou, Junjian Wang, et al.. (2023). The binding mode of orphan glycyl-tRNA synthetase with tRNA supports the synthetase classification and reveals large domain movements. Science Advances. 9(6). eadf1027–eadf1027. 12 indexed citations

Hu, Yiwei, Shuai Ma, Xiaoyan Pang, et al.. (2023). Cytotoxic pyridine alkaloids from a marine-derived fungus Arthrinium arundinis exhibiting apoptosis-inducing activities against small cell lung cancer. Phytochemistry. 213. 113765–113765. 8 indexed citations

Zhang, Yi, Huaxuan Li, Junhua Wang, et al.. (2023). Structure-Based Design and Characterization of the Highly Potent and Selective Covalent Inhibitors Targeting the Lysine Methyltransferases G9a/GLP. Journal of Medicinal Chemistry. 66(12). 8086–8102. 16 indexed citations

10.

Hu, Yiwei, Jian Zhang, Qianyu Wang, et al.. (2022). Therapeutic targeting RORγ with natural product N-hydroxyapiosporamide for small cell lung cancer by reprogramming neuroendocrine fate. Pharmacological Research. 178. 106160–106160. 17 indexed citations

11.

Wang, Junjian, et al.. (2021). Serum exosomes accelerate diabetic wound healing by promoting angiogenesis and ECM formation. Cell Biology International. 45(9). 1976–1985. 35 indexed citations

12.

Wang, Junjian, et al.. (2021). Distribution characteristics and risk assessment of TBBPA in seawater and zooplankton in northern sea areas, China. Environmental Geochemistry and Health. 43(11). 4759–4769. 22 indexed citations

13.

Li, Zhenzhen, Zhen Guo, Rui Lan, et al.. (2020). The poly(ADP-ribosyl)ation of BRD4 mediated by PARP1 promoted pathological cardiac hypertrophy. Acta Pharmaceutica Sinica B. 11(5). 1286–1299. 27 indexed citations

14.

Li, Ziqing, Wenwei Luo, Fang Shi, et al.. (2020). Prostacyclin facilitates vascular smooth muscle cell phenotypic transformation via activating TP receptors when IP receptors are deficient. Acta Physiologica. 231(2). e13555–e13555. 10 indexed citations

15.

Wang, Junjian, et al.. (2019). Tanshinone IIA reduces palmitate‐induced apoptosis via inhibition of endoplasmic reticulum stress in HepG2 liver cells. Fundamental and Clinical Pharmacology. 34(2). 249–262. 18 indexed citations

16.

Zhang, Yan, Ming Song, Xiaoqian Xue, et al.. (2018). Structure-Based Discovery and Optimization of Benzo[d]isoxazole Derivatives as Potent and Selective BET Inhibitors for Potential Treatment of Castration-Resistant Prostate Cancer (CRPC). Journal of Medicinal Chemistry. 61(7). 3037–3058. 49 indexed citations

17.

Wang, Junjian, et al.. (2016). The effect of mechanical stretch stress on the differentiation and apoptosis of human growth plate chondrocytes. In Vitro Cellular & Developmental Biology - Animal. 53(2). 141–148. 18 indexed citations

18.

Chen, Peng, Haibin Wang, Fan Yang, et al.. (2016). Curcumin Promotes Osteosarcoma Cell Death by Activating miR‐125a/ERRα Signal Pathway. Journal of Cellular Biochemistry. 118(1). 74–81. 41 indexed citations

19.

Wang, Junjian, Peng Chen, Jianzhen Xu, et al.. (2015). Transporting Cells in Semi-Solid Gel Condition and at Ambient Temperature. PLoS ONE. 10(6). e0128229–e0128229. 10 indexed citations

20.

Zou, June X., Zhijian Duan, Junjian Wang, et al.. (2014). Kinesin Family Deregulation Coordinated by Bromodomain Protein ANCCA and Histone Methyltransferase MLL for Breast Cancer Cell Growth, Survival, and Tamoxifen Resistance. Molecular Cancer Research. 12(4). 539–549. 143 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact